Pedro C. Barata
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 55
-
- Prostate Cancer Treatment and Research 88
- Renal cell carcinoma treatment 66
- Prostate Cancer Diagnosis and Treatment 20
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 51
- Molecular Biology top 10%
- Renal and related cancers 25
- Surgery top 10%
- Bladder and Urothelial Cancer Treatments 48
-
- Radiopharmaceutical Chemistry and Applications 25
- Co-authors
- Brian I. RiniJorge A. GarcíaOliver SartorDavid S. HongAnil K. SoodPetros GrivasChanning J. PallerVadim S. Koshkin
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Pedro C. Barata
190 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Cancer Research 771
- Pulmonary and Respiratory Medicine 1.4k
- Oncology 846
- Molecular Biology 993
- Surgery 503
Countries citing papers authored by Pedro C. Barata
This map shows the geographic impact of Pedro C. Barata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro C. Barata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro C. Barata more than expected).
Fields of papers citing papers by Pedro C. Barata
This network shows the impact of papers produced by Pedro C. Barata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro C. Barata. The network helps show where Pedro C. Barata may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pedro C. Barata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 7 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 21 | |
| 11 | 2023 | 7 | |
| 12 | 2023 | 21 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2023 | 8 | |
| 16 | 2023 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2023 | 30 | |
| 19 | 2022 | 2 | |
| 20 | 2021 | 39 |
About Pedro C. Barata
Pedro C. Barata is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 218 papers that have together received 2.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (88 papers), Renal cell carcinoma treatment (66 papers), Cancer Genomics and Diagnostics (55 papers), Cancer Immunotherapy and Biomarkers (51 papers), Bladder and Urothelial Cancer Treatments (48 papers), Radiopharmaceutical Chemistry and Applications (25 papers), Renal and related cancers (25 papers) and Prostate Cancer Diagnosis and Treatment (20 papers). The work is most often cited by research in Cancer Research (771 citations), Pulmonary and Respiratory Medicine (1.4k citations) and Oncology (846 citations). Pedro C. Barata has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Brian I. Rini, Jorge A. García, Oliver Sartor, David S. Hong, Anil K. Sood, Petros Grivas, Channing J. Paller, Vadim S. Koshkin, Moshe Chaim Ornstein and Timothy D. Gilligan. Their work appears in journals such as The Lancet, Circulation and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.